(Q35571211)

8 August 2017

1 reference

title

Medulloblastomas and central nervous system primitive neuroectodermal tumors (English)

1 reference

8 August 2017

1 reference

https://api.crossref.org/works/10.1007/S11864-003-0050-7

26 March 2024

author name string

Thomas W. McLean

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585230

26 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14585230

26 March 2024

publication date

1 December 2003

1 reference

full work available at URL

8 August 2017

http://link.springer.com/content/pdf/10.1007/s11864-003-0050-7.pdf

file format

Portable Document Format

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S11864-003-0050-7

http://link.springer.com/article/10.1007/s11864-003-0050-7/fulltext.html

26 March 2024

1 reference

https://api.crossref.org/works/10.1007/S11864-003-0050-7

http://link.springer.com/content/pdf/10.1007/s11864-003-0050-7

26 March 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S11864-003-0050-7

Current Treatment Options in Oncology

26 March 2024

published in

1 reference

8 August 2017

volume

4

1 reference

8 August 2017

issue

6

1 reference

8 August 2017

page(s)

499-508

1 reference

Medulloblastoma: time-dose relationship based on a 30-year review.

8 August 2017

cites work

1 reference

12 December 2020

Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results

1 reference

12 December 2020

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

1 reference

12 December 2020

TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors

1 reference

12 December 2020

Mechanism of transient adrenal insufficiency with megestrol acetate treatment of cachexia in children with cancer

1 reference

12 December 2020

High-dose chemotherapy with autologous stem cell rescue for brain tumors

1 reference

12 December 2020

Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study

1 reference

12 December 2020

Proton beam therapy in the management of central nervous system tumors in childhood: the preliminary experience of the Centre de Protonthérapie d'Orsay

1 reference

12 December 2020

Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children

1 reference

12 December 2020

Surgical management of medulloblastoma

1 reference

12 December 2020

Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital

1 reference

12 December 2020

Protracted radiotherapy treatment duration in medulloblastoma.

1 reference

12 December 2020

Neurological dysfunction associated with postoperative cerebellar mutism.

1 reference

12 December 2020

Postoperative evaluation for disseminated medulloblastoma involving the spine: contrast-enhanced MR findings, CSF cytologic analysis, timing of disease occurrence, and patient outcomes.

1 reference

12 December 2020

Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease

1 reference

12 December 2020

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

1 reference

12 December 2020

Medulloblastoma--challenges in radiation therapy and the addition of chemotherapy.

1 reference

12 December 2020

Childhood medulloblastoma: progress and future challenges

1 reference

12 December 2020

Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study

1 reference

12 December 2020

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

1 reference

12 December 2020

What's new in neuro-oncology? Recent advances in medulloblastoma

1 reference

12 December 2020

Prediction of central nervous system embryonal tumour outcome based on gene expression

1 reference

12 December 2020

Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study

1 reference

12 December 2020

Radiotherapy for medulloblastoma in children: a perspective on current international clinical research efforts

1 reference

12 December 2020

Alternative treatments for childhood brain tumors

1 reference

12 December 2020

Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience

1 reference

12 December 2020

Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy

1 reference

12 December 2020

Identifiers

DOI

1 reference

8 August 2017

1 reference